Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02720185
Title Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Wisconsin, Madison
Indications

triple-receptor negative breast cancer

Therapies

Dasatinib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.